Article
CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells
28 Apr 2016
Abstract excerpt
Glioblastoma (GBM) is one of the most aggressive types of cancer with limited therapeutic options and unfavorable prognosis. Stemness and non-classical epithelial-to-mesenchymal transition (ncEMT) features underlie the switch from normal to neoplastic states as well as resistance of tumor clones to current therapies. Therefore, identification of ligand/receptor systems maintaining this privileged state is needed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
